Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mutations in
SYNE1
have been originally described to cause a slowly progressive, pure cerebellar ataxia (spinocerebellar ataxia, autosomal-recessive 8;
SCAR8
). Notably, recent studies revealed that affected patients with
SYNE1
-associated ataxia can present with complex phenotypes rather than pure cerebellar ataxia, including motor neuron and brainstem dysfunctions. We herein report a Japanese patient diagnosed with juvenile
amyotrophic lateral sclerosis
(
ALS
) with a complex phenotype, who carried compound heterozygous pathogenic variants in
SYNE1
. Of the variants, one was a novel frameshift variant and the other was a nonsense variant previously reported as pathogenic for
SCAR8
. The patient showed an early age at onset with a relatively slow but progressive course of
ALS
, accompanied by cognitive decline. Our findings suggest that the clinical spectrum of patients carrying pathogenic
SYNE1
variants is broader than expected, and
SYNE1
variants should be considered in patients diagnosed with juvenile
ALS
, even without prominent cerebellar ataxia.
...
PMID:Juvenile amyotrophic lateral sclerosis with complex phenotypes associated with novel
SYNE1
mutations. 3287 32